Summary of Purpose
The PROTEMBO SF Trial is a prospective, observational, multi-center, intention-to-treat study of the safety and feasibility of the ProtEmbo Cerebral Protection System in subjects with severe symptomatic native aortic valve stenosis indicated for TAVR.Read More →
The following dates are available for this trial. Trial information last updated on 24 October 2017.
|9 Aug 2017||13 Oct 2017||31 Aug 2018||31 Dec 2018||1 Oct 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|